Prevalence Of BRCA1/2 In An Ovarian Cancer Cohort: Outcomes From A Nationwide Testing Program
Ciara S. McNevin(St. James's Hospital), Karen A. Cadoo(Memorial Sloan Kettering Cancer Center), Sharon O’Toole(Trinity College Dublin), Steven G. Gray(Trinity College Dublin), Cathal Ó’Brien(Molecular Medicine Ireland), Pierre Murchan(St. James's Hospital), Megan O’Shaughnessy(University of Liverpool), Rachel Dillion(St. James's Hospital), Emer Atkinson(Molecular Medicine Ireland), Roshni Deepa Deepa kalachand(University Hospital Limerick), Anne‐Marie Baird(Trinity College Dublin), Niamh Coleman(St. James's Hospital), Brendan Doyle(Molecular Medicine Ireland), Paul Smyth(Molecular Medicine Ireland), Órla Fitzpatrick(Trinity College Dublin), Georgia Thordi(Molecular Medicine Ireland), Stephen P. Finn(Trinity College)
Cited by 0
Related Papers
Circular RNAs: Biogenesis, Function and Role in Human Diseases
|Frontiers in Molecular Biosciences|2017|572
Porous isoreticular non-metal organic frameworks
|Nature|2024|131
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
|The Lancet Oncology|2022|104